Long-term follow-up in hepatitis C patients with respect to immunosuppression.
Mueller
A R
AR
Department of Surgery, Virchow Clinic, Humboldt University, Berlin, Germany.
Platz
K P
KP
Berg
T
T
Fukomoto
T
T
Guckelberger
O
O
Neuhaus
R
R
Bechstein
W O
WO
Hopf
U
U
Lobeck
H
H
Neuhaus
P
P
D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000401:mortality / Q000601:surgery; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology; D006526:Hepatitis C / Q000453:epidemiology* / Q000401:mortality / Q000601:surgery*; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D008113:Liver Neoplasms / Q000453:epidemiology / Q000401:mortality / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D011183:Postoperative Complications; D012008:Recurrence; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus